Researchers used callers, posing as the uninsured, to call primary care offices. They got appointments if they could pay the fee. Things changed, however, if the callers tried to work out a deal by which they would pay in installments. Far fewer callers could get appointments in such cases.
Frequent shift work, particularly at night, increases type 2 diabetes risk factors, according to a study in Diabetes Care. Researchers at Brigham and Women’s Hospital in Boston looked at the impact on 270,000 people who currently work the night shift, using data from the UK Biobank.
At first patients didn’t care that much. Then the monitors improved, and studies showed improved outcomes. But CMS wouldn’t cover them unless they had a ‘nonadjunctive’ indication. Now some envision a time when fingersticks will be a thing of the past for many people with diabetes.
Clinical benefits associated with new cancer therapies do not justify the high prices for the medications, and some value-based payment system is needed, according to a study published in the Journal of Oncology Practice. That’s especially true regarding incremental costs, the difference in total drug price between the novel medications and standard treatment.
A state lawmaker calls insulin prices ‘outrageous.’ PhRMA and BIO are fighting the law in court on grounds that it interferes with their patent rights.